Farina A. Klocksieben

US Food and Drug Administration Approvals of Drugs and Devices Based on Nonrandomized Clinical Trials

John P. A. Ioannidis, Paul Glasziou, Benjamin Djulbegovic, 2019, JAMA network open.

Larger effect sizes in nonrandomized studies are associated with higher rates of EMA licensing approval.

Paul Glasziou, Benjamin Djulbegovic, John P.A. Ioannidis, 2018, Journal of clinical epidemiology.

US Food and Drug Administration Approvals of Drugs and Devices Based on Nonrandomized Clinical Trials: A Systematic Review and Meta-analysis

Farina A. Klocksieben, F. Klocksieben, Iain Chalmers, 2019 .